Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.

Saved in:
Bibliographic Details
Title: Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.
Authors: Wichmann CW; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3052, Australia. Electronic address: christian.wichmann@onjcri.org.au., Poniger S; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; iPHASE technologies Pty Ltd, Rowville, VIC 3178, Australia., Guo N; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Roselt P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Rudd SE; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3052, Australia., Donnelly PS; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3052, Australia., Blyth B; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Van Zuylekom J; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Rigopoulos A; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia., Burvenich IJG; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia., Morandeau L; Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia., Mohamed S; Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, WA 6009, Australia., Nowak AK; Office of Deputy Vice Chancellor (Research), University of Western Australia, Crawley, WA 6009, Australia., Hegi-Johnson F; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., MacManus M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, VIC 3000, Australia; Peter MacCallum Cancer Centre, Melbourne, VIC 3000, Australia., Scott AM; Olivia Newton-John Cancer Research Institute, Heidelberg, VIC 3084, Australia; School of Cancer Medicine, La Trobe University, Bundoora, VIC 3083, Australia; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, VIC 3084, Australia; Faculty of Medicine, The University of Melbourne, VIC 3000, Australia.
Source: Nuclear medicine and biology [Nucl Med Biol] 2023 May-Jun; Vol. 120-121, pp. 108351. Date of Electronic Publication: 2023 May 16.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9304420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9614 (Electronic) Linking ISSN: 09698051 NLM ISO Abbreviation: Nucl Med Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-9614
DOI:10.1016/j.nucmedbio.2023.108351